Form 4: Royalty Pharma Executive Sells Shares
Insider Transaction (Form 4)
Marshall Urist, EVP, Research & Investments of Royalty Pharma plc, sold 4,126 shares of common stock on September 28, 2026 for $57.88 per share.
Summary
- Open-market sale: disposed of 4,126 Class A Ordinary Shares at $57.88 ($238,813) on September 28, 2026; holds 4,126 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $238,813 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Marshall Urist — Officer (EVP, Research & Investments)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-28 | Open-market sale | Class A Ordinary Shares | 4,126 | $58 | $238.8K | 4,126 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-28 | Open-market sale (4,126 shares) |
Keywords
insider transaction, Form 4, RPRX, Royalty Pharma plc, bearish, Marshall Urist
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.